Ethical Principles in Clinical Research

Similar documents
Ethical Principles in Clinical Research. Disclaimer. Christine Grady Department of Bioethics NIH Clinical Center

TOP 10 INVESTIGATOR RESPONSIBILITIES WHEN CONDUCTING HUMAN SUBJECTS RESEARCH

Top Ten Investigator Responsibilities When Conducting Human Subjects Research

Ethical, Legal and Social Issues arising out of Advancements in New Biology. Seyed E. Hasnain

What is an IRB (Institutional Review Board)?

Annual Research Administrators Symposium IRB Compliance. Thursday, July 31, 2014

The Role of the IRB in Clinical Trials: What Patients and Families Need to Know. Marjorie A. Speers, Ph.D. Executive Director, WCG Foundation

S A I N T M A RY S E M I N A RY O C T O B E R 1 9,

Human Subjects Protection: Training for Research Teams

WCG ACADEMY COURSE OVERVIEW

Ethical Issues in Clinical Trial & Development of Regulation Policy on Clinical Research

Ethical Issues, Community Perspective and Standards of Care for Clinical Research on Women & Children in Africa

RESEARCH DURING PUBLIC HEALTH EMERGENCIES- ETHICAL ISSUES

Institutional Review Board

Research: Ethics, Informed Consent, FDA, Off Label Use

Human Subjects Protection Program Plan

Ethics Committees/IRBs Today: Challenges for Efficiency and Quality

Human Research Protection Program Plan

Human Research Protection Program. Plan

Trends in Oversight of Human Research Protections?

Vaccines: Key Issues in Ethics of Study Design and Implementation

Institutional Review Board. Ensuring that the rights and welfare of participants in research are protected.

Advocate Health Care Network. Human Research Protection Program. Plan

Functional Classification of Medicine

Institutional Review Board Compliance Elizabeth City State University

HUMAN RESEARCH PROTECTION PROGRAM PLAN

EIGHT BASIC ELEMENTS OF INFORMED CONSENT

Research, Human Subject Protection & Institutional Review Board (IRB) Jed Delmore, MD

50 SHADES OF GRAY: WHY AND WHEN IS IRB APPROVAL REQUIRED?

Principal Investigator s Procedure Manual for the Protection of Human Subjects (June 2004)

HCCA Compliance Institute

An ethical dilemma: Moving medical research to the developing countries. By: Qianyao Qiu

How did it evolve? o Public disasters, serious fraud and abuse of human rights. o Trials of War criminals-nuremberg code 1949

Human Research Protection Program. Plan

How the Past Influenced Human Research Protection Regulations

Protection of Research Participants: The IRB Process and the Winds of Change

Title: IRB Purpose, Principles and Responsibilities Page: 1 of 5

University of the Virgin Islands Institutional Review Board (IRB) IRB Basics for Social Science Senior Seminar (STT/STX)

Good Clinical Practice. Martin Rose, MD, JD February 8, 2018 ASQ

Volunteering for Clinical Trials

Research Data Sharing and Security: The Challenges We Face. Jon Mark Hirshon, MD, PhD, MPH Senior Vice-Chair Institutional Review Board

WMA Declaration of Helsinki Ethical Principles f or Medical Research Involving Human Subjects

Ethics of Radiation Protection in Medicine

WMA Declaration of Helsinki - Ethical

CHECKLIST: Pre-review

Institutional Review Board (IRB)

Rules of Human Experimentation

USE OF INVESTIGATIONAL DRUGS OR BIOLOGICS IN HUMAN SUBJECTS RESEARCH

APPLICATION FORM. Application for a Recognised Research Ethics Committee (REC) Opinion on a Clinical Trial on a Medicinal Product for Human Use.

Amanda A. Hastings, MSHL Education Specialist USF Division of Research Integrity & Compliance

Human Research Protection Program Guidance for Human Research Determination

Ethics. A. As a Statistician / Statistical Consultant B. Human Subjects Research Protections

Vicki Rigolo Stecher, M.A., CIP IRB Education Coordinator USF Division of Research Integrity & Compliance

Regulatory Protection of Human Subjects in Research

UCI ADMINISTRATIVE POLICIES & PROCEDURES

Current Issues Regarding Data and Safety Monitoring Committees in Clinical Trials

INSPECTION OF INDEPENDENT ETHICS COMMITTEES (IEC) The Italian Experience

PROTOCOL DRAFTING GUIDE

COI IN THE MEDIA 10/8/2012 CONFLICT OF INTEREST IN HUMAN SUBJECT RESEARCH HIGH PROFILE CONFLICT OF INTEREST CASES INVOLVING HUMAN SUBJECTS

Office for Human Subject Protection. University of Rochester

Outline of Discussion

Institutional Review Board for the Protection of Human Subjects

These are dramatic cases that captured public attention and led to the development of regulations designed to protect research participants.

World Medical Association Declaration of Helsinki

Human Subjects Research: IRB Resources

Should Research Subjects be Paid? How much is too much? How can we standardize payment? April 17 th, 4.30 PM

1 Human Subjects Protection Training Manuel

Title: Review of Medical Devices Page: 1 of 5 Written by:

Biomedical Research on Human Participants

PREP Course 24: Defining the Differences between FDA and OHRP regulations. Presented by: Hallie Kassan Dorean Flores Office of the IRB

Effective Date: April 2014 Revision: September 29, 2017

Clinical Research: A Multifaceted Discipline

Pharmaceutical companies are turning to private practices to conduct clinical trials. An insider tells you what you need to know and what to avoid in

Learning about Clinical Trials

Northwestern University HSPP Policy Manual Page 2 of 116

Human Subjects Research

Expedited Review of Human Subject Research

PARTICIPANT RIGHTS AND PRIVACY. Tammy Stewart, CHRC & Jenny Bernhard, CHPC, CHC

Ethics of pragmatic trials: Considerations for informed consent

Brain Tumour Australia Information FACT SHEET 22 Clinical Trials: Questions and Answers

SOCIAL & BEHAVIORAL TEMPLATE WITH INSTRUCTIONS: 2.0 Background / Literature Review / Rationale for the study:

Elyse I. Summers, J.D. President and CEO. Copyright 2018 AAHRPP All rights reserved.

Implementation of the EU-law. Tom Van Paepegem Quality co-ordinator D.R.U.G.

ETHICAL ISSUES IN CANCER CLINICAL TRIALS

HANDBOOK FOR GOOD CLINICAL RESEARCH PRACTICE (GCP)

About Clinical Trials

Human Research Protections Program Policies and Standard Operating Procedures

Final Rule Material: Secondary Research with Identifiable Information and Biospecimens

Clinical trials patient-education brochure

Seamless Cancer Drug Development: Patient Protections & Ethical Considerations

Investigator Manual. Human Subjects Protection Program

INSTITUTIONAL ETHICS REVIEW COMMITTEE GLOSSARY

Statement on Regulatory Systems to Improve Pharmaceutical Safety

\\NAS1\George\Docs\SoCRA\CCRP communications\study guide management

International Research Bridging Bioethics and Practice

BO STO N MEDTECH. More Experience Better Results. Ethics in Clinical Research. Zvi Ladin, Ph.D.

APPLICATION INSTRUCTIONS INSTITUTIONAL REVIEW BOARD. Revised January 2010 Page 1

Ethical considerations for clinical trials on medicinal products conducted with the paediatric population

Guidelines. for ethical conduct of biomedical research involving human subjects in Kenya. National Council for Science and Technology.

FREQUENTLY ASKED QUESTIONS

Transcription:

Ethical Principles in Clinical Research Christine Grady NIH Clinical Center Department of Bioethics No conflicts of interest. Views presented are mine and do not necessarily represent positions or policies of the Department of Bioethics, Clinical Center, National Institutes of Health, or DHHS What makes clinical research ethical? Dr. Progress proposes a placebo controlled study of a new promising drug in adults and children with a serious disease. How do we know whether or not the proposed study is ethical? 1

Moral problem in clinical research The goal of clinical research is to generate useful knowledge about human health and illness, and methods of preventing, diagnosing and treating diseases. The goal of research is not benefit to the individuals who participate (although there is sometimes benefit) People are thus the means to developing useful knowledge and at risk of exploitation Ethics of Clinical Research Ethical requirements in clinical research aim to: minimize the possibility of exploitation; ensure that the rights and welfare of subjects are respected while they contribute to the generation of knowledge. Codes and Guidelines Nuremberg Code (1949) Declaration Of Helsinki (1964-2000, 2008?) The Belmont Report (1979) CIOMS/WHO International Guidelines (1993, 2002) ICH/GCP-International Conference on Harmonization- Good Clinical Practice 2

THE BELMONT REPORT Ethical principles underlying the conduct of research: Respect for persons Beneficence Justice Distinction between clinical research and clinical practice Goals Methods Risks The Belmont Report U.S. Regulations and Guidelines The Common Rule (US 45CFR.46) FDA regulations (US 21CFR50 and 56, and others) NIH policy and guidelines 3

45CFR.46 Protection of Human Subjects Composition and function of a local institutional review board (IRB) Criteria for IRB approval of research proposals Requirements regarding informed consent 45CFR 46 Subpart B- Fetuses, pregnant women, and human in vitro fertilization Subpart C- Prisoners as subjects Subpart D- Children FDA REGULATIONS 21CFR.50 Protection of Human Subjects (informed consent) Subpart D on research with children 21CFR.56 IRB composition and function 4

Existing guidance Most developed in response to specific problems Some issues incompletely addressed, include divergent recommendations Need for a systematic, coherent, universally applicable framework Ethical framework: 7 principles Valuable scientific question Valid scientific methodology Fair subject selection Favorable risk-benefit evaluation Independent review Informed consent Respect for enrolled subjects Emanuel E, Wendler D, Grady C. What makes clinical research ethical? Journal of the American Medical Association 2000; 283(20):2701-11 Valuable Scientific Question Ethical clinical research should answer a valuable question, i.e., one that will generate new knowledge or understanding about human health or illness, i.e. a socially, clinically, or scientifically useful question 5

Social/scientific/clinical value What treatments are already available for the disease that Dr. Progress wants to study? How safe and effective are they? What is the reason for/value of testing a new treatment? What about the particular drug suggests it might offer added value? Will this study as proposed answer a valuable and unsettled question? Valid Scientific Methodology Ethical clinical research should be designed in a methodologically rigorous manner (design, methods, statistical power and methods, etc.) that will yield valid, reliable, generalizable, and interpretable data, and that is feasible Scientific validity Is Dr. Progress s study designed rigorously enough to answer the research question? Dose and duration of treatment, size and characteristics of sample, outcome measures, etc. Is the placebo control design justified? Is the study feasible (will people enroll?), can the data be collected, etc. 6

Fair subject selection Scientific objectives should guide inclusion criteria, recruitment strategies, and selection (not privilege or easy availability or vulnerability) Fairly distribute harms and benefits No exclusion without justification Fair subject selection What are the eligibility/exclusion criteria for Dr. Progress s study? What justifications are sufficient i for exclusion? Is inclusion of children justified? Are certain groups at particular risk of harm? Or more likely to benefit? Research as burden or benefit? Research as burden Subjects need protection Research as benefit Subjects need access 7

Favorable risk-benefit Are risks to subjects necessary and minimized? Are risks justified by benefit to individual subjects and/or the importance of the knowledge to society? Are benefits maximized? Risks in research What are the possible risks in the proposed RCT? Probability and magnitude Types of risk Uncertainty Minimizing risks Limiting risk Benefits in research What are the potential benefits? Direct versus secondary benefits Maximizing benefits Balancing risks and benefits 8

Benefits and Risks in Research [I]nterests other than those of the subject may on some occasions be sufficient by themselves to justify the risks involved in the research, so long as the subjects rights have been protected. The Belmont Report Independent review To ensure ethical requirements have been fulfilled To check investigator biases and conflicts To assure the public that research is not exploiting individuals or groups Criteria for IRB Review (45CFR.46.111 and 21CFR56.111) Risks are minimized. Risks are justified by anticipated benefits, if any, to the subjects or the importance of the knowledge to be gained Subjects will be selected and treated fairly Informed consent is adequate 9

Informed Consent Informed consent ensures that individuals have the opportunity to decide whether they want to participate in research or continue participation and whether it is compatible with their goals, values and interests Informed Consent The voluntary consent of the human subject is absolutely essential. Nuremberg Code For all biomedical research involving human subjects, the investigator must obtain the informed consent of the prospective subject or authorized representative. CIOMS guidelines Informed Consent To the degree subjects are capable, they should be given the opportunity to choose what shall or shall not happen to them. The Belmont Report Extra protections for those with limited capacity to consent 10

Informed consent Disclosure of information Understanding Voluntary decision making Authorization Informed Consent Federal regulations require the following information in the consent form 1) That it is research, the purpose, duration, and nature of the procedures 2) Risks 3) Benefits 4) Alternatives 5) Confidentiality of records 6) Compensation for injuries 7) Person to contact for answers to questions 8) Voluntariness and right to withdraw 11

IRB review Does the plan for informing participants or LAR about the objectives, risks, benefits, and alternatives of the study, assessing understanding, and seeking their voluntary agreement seem adequate? Respect for enrolled subjects Ethical research requires continued respect for the rights and welfare of participants throughout research, including: Protecting confidentiality Monitoring welfare Recognizing right to withdraw Providing new information Informing participants of findings Post trial planning Respect for enrolled subjects During the course of the experiment the human subject should be at liberty to bring the experiment to an end Nuremberg Code Every precaution should be taken to respect the privacy of the subject,the confidentiality of the subject s information, and to minimize the impact of the study on physical and mental integrity and on the personality of the subject. Helsinki 2000 12

7 principles Valuable scientific question Valid scientific methodology Fair subject selection Favorable risk-benefit evaluation Independent review Informed consent Respect for enrolled subjects Framework Systematic and sequential Necessary Procedural requirements may be waived Universal Adapted and implemented according to context Require balancing, specifying Balancing principles Example: Randomized Controlled Trials Balancing the need for a rigorous design Balancing the need for a rigorous design with the obligation to maximize benefits and minimize harms 13

Case In a clinical trial testing the safety and efficacy of a novel intervention that has promise as an important treatment- is it ethically ypreferable to enroll mildly-moderately ill young adults or severely ill children? Stress informed consent Adults should be enrolled because they can consent. As long as the scientific question can be answered by enrolling people who are capable of giving consent, it is not necessary to enroll patients who cannot consent. Stress risk-benefit and social value Informed consent is not an absolute requirement. Young children may be at least as well off in the trial as in clinical care and will be contributing to scientific knowledge. Finding an effective treatment is more important for those with severe disease. The risk/benefit assessment is also more favorable since the severely ill infants have more to gain from successful treatment and less to lose if they suffer side effects than do mildly ill young adults 14

Cannot enroll ill infants since they are vulnerable Stay tuned Links to more information http://www.wma.net http://www.cioms.ch http://ohrp.osophs.dhhs.gov p p p g http://ohsr.od.nih.gov http://www/fda.gov http://grants.nih.gov/grants/policy/hs/index.htm http://cme.nci.nih.gov 15